Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (126)

1

Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors : blockage of its enzymatic activity and interference with fungal growth and macrophage interaction

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2020

von Granato, M. | Sousa, I. | Rosa, T. | +6

2

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Feng, H. | Caro, L. | Fandozzi, C. | +21

3

GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants

enthalten in: Antimicrobial agents and chemotherapy | 2018

von Delino, N. | Aoki, M. | Hayashi, H. | +7

4

A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413

enthalten in: Antimicrobial agents and chemotherapy | 2016

von Amano, M. | Salcedo-Gómez, P. | Zhao, R. | +7

5

Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain

enthalten in: Journal of medical virology | 2016

von Pernas, B. | Grandal, M. | Tabernilla, A. | +7

6

HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance

enthalten in: AIDS (London, England) | 2016

von Vivithanaporn, P. | Asahchop, E. | Acharjee, S. | +2

7

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial

enthalten in: PloS one | 2016

von Cooper, D. | Cordery, D. | Zajdenverg, R. | +87

8

Effect of Methamphetamine on Spectral Binding, Ligand Docking and Metabolism of Anti-HIV Drugs with CYP3A4

enthalten in: PloS one | 2016

von Nookala, A. | Li, J. | Ande, A. | +5

9

A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2014

von Pérez-Valero, I. | González-Baeza, A. | Estébanez, M. | +11

CommentIn: Clin Infect Dis. 2014 Dec 1;59(11):1635-7. - PMID 25114033

10

A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral therapy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2014

von Estébanez, M. | Stella-Ascariz, N. | Mingorance, J. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]